General Information
Revision date
2011-03-03
Product name
CUPFERRON
Product Synonyms
Ammonium N-hydroxy-N-nitrosobenzenamine; ammonium salt of N-nitrosophenylhydroxylamine;
CAS No.
135-20-6
1.2.1 Relevant identified uses
Inhibitor NPH;Benzenamine,N-hydroxy-N- nitroso-,ammonium salt
Icons in SDS
Company Information
company name
Avantor Performance Materials, Inc.
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
Emergency Overview -------------------------- WARNING! POSSIBLE CANCER HAZARD. MAY CAUSE CANCER BASED ON ANIMAL DATA. Risk of cancer depends on duration and level of exposure. CAUSES IRRITATION TO SKIN, EYES AND RESPIRATORY TRACT. HARMFUL IF SWALLOWED, INHALED OR ABSORBED THROUGH SKIN. SAF-T-DATA(tm) Ratings (Provided here for your convenience) ----------------------------------------------------------------------------------------------------------- Health Rating: 3 - Severe (Cancer Causing) Flammability Rating: 1 - Slight Reactivity Rating: 1 - Slight Contact Rating: 2 - Moderate (Life) Lab Protective Equip: GOGGLES; LAB COAT; VENT HOOD; PROPER GLOVES
Storage
Color Code Blue (Health) -----------------------------------------------------------------------------------------------------------
Potential health effects
The acute and chronic systemic toxicity in man from exposure to Cupferron-ammonium salt (NPH/NH4) has not been well documented; however, any exposure may constitute a route of absorption. Inhalation: May cause irritation to the respiratory tract. Symptoms may include coughing and shortness of breath. Ingestion: Toxic. May cause some gastrointestinal disturbances. Animal studies suggest that oral ingestion causes acute systemic effects. Skin Contact: Causes irritation to skin. Symptoms include redness, itching, and pain. May be absorbed through the skin with possible systemic effects. Eye Contact: Causes irritation, redness, and pain. Chronic Exposure: Chronic exposure may occur from inhalation, ingestion or skin absorption. A bioassay was conducted by the National Cancer Institute (NCI) by feeding diets ranging from 0.15 percent to 0.4 percent NPH/ammonium salt to rats and mice. Under conditions of the bioassay, NPH showed dose-related carcinogenic effects. In addition to causing hemangiosarcomas, the primary target organs were the forestomach, liver, auditory sebaceous glands, and the harderian glands. Aggravation of Pre-existing Conditions: Persons with pre-existing skin disorders or eye problems, or impaired liver or respiratory function may be more susceptible to the effects of the substance.